(AP) HERSHEY, Pa. – A 14-year-old boy and his mother will receive $700,000 from the settlement of an AIDS discrimination lawsuit against a private boarding school that refused to enroll …
AHF to Take a Leading Role in HIV/AIDS Research
Respected AIDS researcher and clinician Dr. Otto O. Yang, Professor and Associate Chief of Infectious Diseases at the David Geffen School of Medicine at UCLA, to serve as the inaugural …
F.D.A. Approves Once-a-Day Pill for H.I.V.
August 27, 2012 By ANDREW POLLACK The New York Times The Food and Drug Administration approved a new once-a-day H.I.V. treatment from Gilead Sciences that contains four different drugs in …
AHF To Sponsor S.F. Ballot Initiative to Counter Gilead Drug Price Gouging
Measure comes on heels of news that Bay Area’s Gilead Sciences priced its newly FDA-approved four-in-one AIDS treatment, Stribild, at $28,500 per patient, per year – 37% more than Gilead’s …
Gilead Sciences Faces Pressure to Keep Price Low on New HIV Drug
By: Peter Loftus Dow Jones News Wires August 22, 2012 Gilead Sciences Inc. (GILD) may get clearance by next week to sell what is expected to become a blockbuster HIV …
Porn industry calls for temporary shutdown after reported syphilis cases
August 20, 2012 LA Times A Los Angeles-based trade group that represents adult film companies has called for a nationwide moratorium on production while porn performers are tested for syphilis. …
AIDS HEALTHCARE FOUNDATION ACQUIRES MOMS PHARMACY
Agreement Establishes National Leader in Specialized Pharmacy Services Focused on HIV/AIDS Care LOS ANGELES, CA & MELVILLE, NY (August 20, 2012) AIDS Healthcare Foundation (AHF), the largest nonprofit global HIV/AIDS …
L.A. Porn Industry Shuts Down Over Syphilis Outbreak
AHF Press Conference Monday, August 20th 10am, Hollywood; Incident shows self-policing and testing alone do not work LOS ANGELES (August 19, 2012)Following news that the multi-billion dollar Los Angeles-based …
As Gilead prepares to price the ‘Quad,’ 20 California legislators say AIDS drug pricing “unsustainable”
Twenty Members of the state legislature cosign a letter to Dr. Ron Chapman, Director of California’s Department of Public Health, encouraging the State of California to, “ … employ …
AHF asks state health departments & AIDS directors, private insurers to place Gilead’s new ‘Quad’ pill on ‘Prior Authorization’ status
Gilead’s once-daily ‘Quad’ pill—expected to get FDA approval within the next two weeks—is expected to be priced thousands of dollars higher than current drugs purchased by state programs without representing …